by KeyaMedical | Feb 4, 2025 | Blog, Conferences
Keya Medical’s advanced AI solutions and the application of Deep Learning CT-derived Fractional Flow Reserve analysis in non-invasive cardiac diagnostics. Visit us at SCCT 2025, Booth 14.
by KeyaMedical | Jan 11, 2024 | All News, Blog
Visit Keya Medical’s booth at SCCT Global 2024 in Budapest, January 16-19.
by KeyaMedical | Sep 25, 2023 | All News, Blog
In the dynamic landscape of medical innovation, SCCT 2023 served as an exceptional platform for exchanging cutting-edge insights and breakthroughs in cardiovascular technology.
by KeyaMedical | Jan 4, 2023 | All News, Blog
Keya Medical US celebrates the achievements of the team in China and their commitment to the commercialization of DEEPVESSEL FFR.
by KeyaMedical | Apr 4, 2022 | Blog, Press
Seattle, WA– April 1, 2022– Keya Medical announced that DEEPVESSEL FFR (DVFFR), has been cleared by U.S. Food and Drug Administration (FDA).
by KeyaMedical | Nov 29, 2021 | Blog
Coronary Artery Calcium (CAC) scores have become increasingly important in assessing risk for coronary artery disease. Although non-contrast CT scans are typically used for CAC scoring, calculating CAC scores from CTAs directly could add further value to CTAs as a...
Recent Comments